Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The "Metabolically-obese Normal-weight" Phenotype in Two Asian Ethnic Groups and Its Reversal by Calorie Restriction

NCT03239782 is registered in ClinicalTrials.gov with Singapore Institute of Food and Biotechnology Innovation as lead sponsor.

NCT NCT03239782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03239782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The "Metabolically-obese Normal-weight" Phenotype in Two Asian Ethnic Groups and Its Reversal by Calorie Restriction
Lead sponsor
Singapore Institute of Food and Biotechnology Innovation
Phase
Not applicable
Overall status
Completed
Start date
March 29, 2016
Completion date
October 7, 2017
Enrollment
77 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glucose metabolism disorders, insulin sensitivity/resistance, obesity, visceral, obesity; endocrine